TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia July 26, 2002
TCL Archive Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening October 28, 2011